{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:37:28Z","timestamp":1792787848077,"version":"4.5.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"German Ministry of Health","award":["IIA5-2512FSB053"],"award-info":[{"award-number":["IIA5-2512FSB053"]}]},{"name":"German Federal Institute for Drugs and Medical Devices","award":["V-6308\/68605\/2011-2014"],"award-info":[{"award-number":["V-6308\/68605\/2011-2014"]}],"id":[{"id":"https:\/\/ror.org\/05ex5vz81","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reproductive Toxicology"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.reprotox.2016.01.002","type":"journal-article","created":{"date-parts":[[2016,1,21]],"date-time":"2016-01-21T14:30:58Z","timestamp":1453386658000},"page":"29-32","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Pregnancy outcome after tocilizumab therapy in early pregnancy-a case series from the German Embryotox Pharmacovigilance Center"],"prefix":"10.1016","volume":"60","author":[{"given":"Corinna","family":"Weber-Schoendorfer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christof","family":"Schaefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.reprotox.2016.01.002_bib0005","unstructured":"U.S. Food and Drug Administration, 2010. Drug Approval Package; Actemra (Tocilizumab) Injection. FDA 2010 [cited 2015 Aug 10]; Available from: URL: http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2010\/125276s000TOC.cfm."},{"issue":"Suppl. 1","key":"10.1016\/j.reprotox.2016.01.002_bib0010","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S1297-319X(10)70001-4","article-title":"Tocilizumab: therapy and safety management","volume":"77","author":"Pham","year":"2010","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.reprotox.2016.01.002_bib0015","first-page":"384","article-title":"First experiences with pregnancies in ra patients (pts) Receiving Tocllizumab (TCZ) therapy [abstract]","volume":"62","author":"Rubbert-Roth","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.reprotox.2016.01.002_bib0020","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1136\/annrheumdis-2012-eular.3040","article-title":"Pregnancy in patients with rheumatoid arthritis treated witn biological agents: Results of the 8-year of Japanese TBC Registry [abstract]","volume":"71","author":"Ishikawa","year":"2013","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.reprotox.2016.01.002_bib0025","unstructured":"European Medicines Agency, 2014. Assessment report RoActemra. EMA 2014 [cited 2015 Aug 10]; Available from: URL: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Assessment_Report_-_Variation\/human\/000955\/WC500173868.pdf."},{"key":"10.1016\/j.reprotox.2016.01.002_bib0030","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/nyas.12456","article-title":"Safety issues of biologics in pregnant patients with rheumatic diseases","volume":"1317","author":"Ostensen","year":"2014","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.reprotox.2016.01.002_bib0035","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/ajmg.a.35223","article-title":"Teratogenicity of mycophenolate confirmed in a prospective study of the European Network of Teratology Information Services","volume":"158A","author":"Hoeltzenbein","year":"2012","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.reprotox.2016.01.002_bib0040","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1093\/rheumatology\/ket390","article-title":"No evidence for an increased risk of adverse pregnancy outcome after paternal low-dose methotrexate: an observational cohort study","volume":"53","author":"Weber-Schoendorfer","year":"2014","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.reprotox.2016.01.002_bib0045","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/art.38368","article-title":"Pregnancy outcome after methotrexate treatment for rheumatic disease prior to or during early pregnancy: a prospective multicenter cohort study","volume":"66","author":"Weber-Schoendorfer","year":"2014","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.reprotox.2016.01.002_bib0050","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1111\/bcp.12642","article-title":"Pregnancy outcome after TNF-alpha inhibitor therapy during the first trimester: a prospective multicentre cohort study","volume":"80","author":"Weber-Schoendorfer","year":"2015","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.reprotox.2016.01.002_bib0055","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.zefq.2012.11.012","article-title":"[Drug safety in pregnancy\u2014the Embryotox project]","volume":"106","author":"Schaefer","year":"2012","journal-title":"Z. Evid. Fortbild. Qual. Gesundhwes."},{"key":"10.1016\/j.reprotox.2016.01.002_bib0060","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.reprotox.2008.05.064","article-title":"Using observational cohort data for studying drug effects on pregnancy outcome\u2014methodological considerations","volume":"26","author":"Schaefer","year":"2008","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.reprotox.2016.01.002_bib0065","unstructured":"Stastistisches Bundesamt, 2015. Anzahl von Kaiserschnitten und Geburten insgesamt in Deutschland in den Jahren von 2004 bis 2013. statista 2015 [cited 2015 Aug 10]; Available from: URL: http:\/\/de.statista.com\/statistik\/daten\/studie\/71897\/umfrage\/entbindungen-und-entbindungen-per-kaiserschnitt-in-deutschland\/."},{"key":"10.1016\/j.reprotox.2016.01.002_bib0070","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1093\/oxfordjournals.aje.a113220","article-title":"Spontaneous abortion over time: comparing occurrence in two cohorts of women a generation apart","volume":"114","author":"Wilcox","year":"1981","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.reprotox.2016.01.002_bib0075","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1093\/oxfordjournals.aje.a009747","article-title":"Estimates of the annual number of clinically recognized pregnancies in the United States, 1981\u20131991","volume":"149","author":"Saraiya","year":"1999","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.reprotox.2016.01.002_bib0080","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1136\/bmj.320.7251.1708","article-title":"Maternal age and fetal loss: population based register linkage study","volume":"320","author":"Nybo Andersen","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.reprotox.2016.01.002_bib0085","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.reprotox.2008.06.006","article-title":"Statistical methods for estimating the probability of spontaneous abortion in observational studies\u2014analyzing pregnancies exposed to coumarin derivatives","volume":"26","author":"Meister","year":"2008","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.reprotox.2016.01.002_bib0090","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1586\/eci.11.60","article-title":"Understanding the link between the IL-6 cytokine family and pregnancy: implications for future therapeutics","volume":"7","author":"Markert","year":"2011","journal-title":"Expert Rev. Clin. Immunol."},{"key":"10.1016\/j.reprotox.2016.01.002_bib0095","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/aogs.12324","article-title":"Rheumatoid arthritis and outcomes in first and subsequent births based on data from a national birth registry","volume":"93","author":"Wallenius","year":"2014","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"10.1016\/j.reprotox.2016.01.002_bib0100","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1093\/oxfordjournals.humrep.a137755","article-title":"Determination of protein pattern in embryonic cavities of human early pregnancies: a means to understand materno-embryonic exchanges","volume":"7","author":"Gulbis","year":"1992","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.reprotox.2016.01.002_bib0105","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.reprotox.2013.11.004","article-title":"Pregnancy outcome following gestational exposure to TNF-alpha-inhibitors: a prospective comparative, observational study","volume":"43","author":"Diav-Citrin","year":"2014","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.reprotox.2016.01.002_bib0110","first-page":"688","article-title":"Prospectively-followed pregnancies in patients with inflammatory arthritis taking biological drugs: an Italian multicentre study","volume":"33","author":"Bazzani","year":"2015","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.reprotox.2016.01.002_bib0115","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.reprotox.2010.01.008","article-title":"A pilot study of paternal drug exposure: the Motherisk experience","volume":"29","author":"Lee","year":"2010","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.reprotox.2016.01.002_bib0120","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1742-7843.2007.00162.x","article-title":"Evidence for a role of paternal exposures in developmental toxicity","volume":"102","author":"Cordier","year":"2008","journal-title":"Basic Clin. Pharmacol. Toxicol."}],"container-title":["Reproductive Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890623816300028?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890623816300028?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:40:32Z","timestamp":1760190032000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890623816300028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":24,"alternative-id":["S0890623816300028"],"URL":"https:\/\/doi.org\/10.1016\/j.reprotox.2016.01.002","relation":{},"ISSN":["0890-6238"],"issn-type":[{"value":"0890-6238","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pregnancy outcome after tocilizumab therapy in early pregnancy-a case series from the German Embryotox Pharmacovigilance Center","name":"articletitle","label":"Article Title"},{"value":"Reproductive Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.reprotox.2016.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}